Incyte (INCY) EPS (Basic) Growth (5y) (2015 - 2026)
Incyte (INCY) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.26% |
| Dec 31, 2025 | 17.41% |
| Sep 30, 2025 | 101.47% |
| Jun 30, 2025 | 9.36% |
| Mar 31, 2025 | 17.56% |
| Dec 31, 2024 | 13.47% |
| Sep 30, 2024 | -1.50% |
| Jun 30, 2024 | -43.82% |
| Mar 31, 2024 | 9.58% |
| Dec 31, 2023 | 22.56% |
| Sep 30, 2023 | 40.99% |
| Jun 30, 2023 | 29.86% |
| Mar 31, 2023 | 20.12% |
| Dec 31, 2022 | 16.82% |
| Sep 30, 2022 | 23.80% |
| Jun 30, 2022 | 69.44% |
| Mar 31, 2022 | 16.86% |
| Dec 31, 2021 | 122.20% |
| Sep 30, 2021 | 33.22% |
| Jun 30, 2021 | -67.36% |